Effects Of Neurocognitive Therapy With And Without Soft Robotic Hand On Hand Function

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 7, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring how effective a type of therapy called neurocognitive therapy is for improving hand function in stroke patients. Specifically, it looks at whether adding a soft robotic hand to this therapy makes a difference in how well patients can move their hands, grip objects, and perform daily activities. The study will involve patients who have had their first stroke and are in the recovery phase, which is typically 6 to 12 weeks after the stroke occurred.

To participate in the trial, individuals must be adults who can understand and agree to join the study. They should have mild spasticity (muscle stiffness) and a certain level of cognitive function. However, those with other significant neurological issues, severe cognitive problems, or certain medical implants cannot participate. The trial is not yet recruiting, but once it starts, participants can expect to receive either the therapy alone or the therapy combined with the robotic hand, helping researchers understand the best ways to support recovery after a stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants of Post stroke patients (6-12 weeks )
• • Participants with Spasticity \< 2 on modified Ashworth scale.
• • Participants with first ever stroke.
• • Participants with normal cognition \> 24 on MoCA
• • Participants must be able to provide informed consent
• • Hemiparesis with arm motor deficit as assessed by with NIHSS \>1(14)
• Exclusion Criteria:
• • Participants who have a history of significant neurological or orthopedic disorders, other than stroke, that could interfere with upper limb motor or sensory recovery.
• • Participants who have altered state of consciousness, severe aphasia, severe cognitive deficit.
• • Participants who have severe pathologies of traumatic and or rheumatic nature, severe pain in effected arm (\>5 on visual analog scale for pain) .
• • Participants who have active pacemakers and other active implants.